Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Drops By 72.8%

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 4,100 shares, a decrease of 72.8% from the May 31st total of 15,100 shares. Based on an average daily trading volume, of 405,800 shares, the days-to-cover ratio is presently 0.0 days.

CNBX Pharmaceuticals Stock Performance

CNBX traded down $0.00 during trading hours on Thursday, hitting $0.01. 73,100 shares of the company’s stock were exchanged, compared to its average volume of 267,336. CNBX Pharmaceuticals has a 1-year low of $0.01 and a 1-year high of $0.05. The stock’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.01.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.